Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)
<sup>64</sup>Cu-bisPSMA-PET/CT identifies a higher number of disease recurrences than <sup>68</sup>Ga PSMA-PET/CT with substantial management impact and a high RS true positive rate in men with BCR post RP.
Authors
- Phillip D. Stricker (ORCID: https://orcid.org/0000-0002-0934-0656)
- Joanna Olphert
- Jeff Chen (ORCID: https://orcid.org/0000-0003-4553-9221)
- Hester Lieng
- Louise Emmett (ORCID: https://orcid.org/0000-0002-4895-7384)
- Thomas Eade (ORCID: https://orcid.org/0000-0003-4324-1886)
- Andrew Kneebone (ORCID: https://orcid.org/0000-0002-7629-504X)
- Shraddha Weir
- Nathan Papa (ORCID: https://orcid.org/0000-0002-3188-1803)
- Raji Kooner
- Jordan Idiare
- Kris Rasiah
- Bao Ho
- Shikha Sharma
- Jeremy de Leon
- Sobia Khan
- Narjess Ayati
- Matthew J Roberts
- George Hruby
- Keith Wong
- James Thompson
- Katrina Devitt
- George Sidhom
- Andrew Nguyen
Institutions
- Garvan Institute of Medical Research (AU)
- Royal Brisbane and Women's Hospital (AU)
- Royal North Shore Hospital (AU)
- St Vincent's Hospital Melbourne (AU)
- St Vincent's Hospital Sydney (AU)
- St Vincent’s Private Hospital Sydney (AU)
- St George Hospital (AU)
- St Vincent's Clinic (AU)
- Central Coast Local Health District (AU)
Publication Details
- Journal
- European Urology
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1016/j.eururo.2026.03.001
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00